
Ecogrel 5mg Tablet
Marketer
Delvin Formulations Pvt Ltd
Salt Composition
Prasugrel (5mg)
Overview Ecogrel 5mg Tablet
Cardiogard 5mg tablets are antiplatelet agents, also known as blood thinners. They prevent dangerous blood clots, ensuring smooth blood flow. This reduces the risk of subsequent heart attacks or strokes in individuals with cardiac conditions. Cardiogard 5mg is indicated for patients recovering from a recent heart attack, experiencing severe angina, or post-stent placement. It safeguards against further cardiac events, including recurrent heart attacks, strokes, and stent thrombosis. This medication may be co-administered with aspirin, another antiplatelet drug. It can be taken with or without food, consistently at the same time daily. Continuous use is vital, even with symptom resolution; discontinuation raises the risk of cardiovascular events. The most common adverse effect is bleeding, manifesting as bruising, epistaxis, hematuria, melena (dark stools), or heavier menstrual bleeding. Wound healing may be prolonged. While most bleeding episodes are mild and self-limiting, persistent or concerning bleeding requires immediate medical attention. This medication is contraindicated in patients with active internal bleeding (e.g., peptic ulcer, intracranial hemorrhage) or severe hepatic impairment. Prior to initiating treatment, inform your physician of any bleeding disorders, recent significant trauma, or upcoming surgery. Cardiogard may require temporary cessation before scheduled surgical or dental procedures.
Primary Ingredients of Ecogrel 5mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Ecogrel 5mg Tablet
Avoiding Heart Attacks and Strokes
Major Benefits of Ecogrel 5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Ecogrel 5mg Tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, however, consistent timing is recommended.
Common Side effects of Ecogrel 5mg Tablet:
- Bleeding
How to use Ecogrel 5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ecogrel 5mg tablets can be consumed with or without food, although consistent timing is recommended.
How Ecogrel 5mg Tablet works:
Plavix 5mg tablets offer antiplatelet action, inhibiting platelet aggregation to reduce the risk of dangerous blood clots. This significantly diminishes the likelihood of recurrent stroke or heart attack.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Ecogrel 5mg Tablet and alcohol.
PregnancyCONSULT YOUR DOCTOR
Data on Ecogrel 5mg Tablet use in pregnancy is lacking. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Ecogrel 5mg Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Ecogrel 5mg Tablets.
KidneySAFE IF PRESCRIBED
Use of Ecogrel 5mg tablets in patients with kidney disease appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use Ecogrel 5mg tablets cautiously, potentially requiring dose modification. Consult a physician for guidance as data on Ecogrel 5mg tablet use in this population is limited. No dose alteration is necessary for individuals with mild or moderate liver dysfunction.
What if you forget to take Ecogrel 5mg Tablet :
Should you forget a dose of Ecogrel 5mg Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ecogrel 5mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Piperazine-based compound |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | ADP receptor antagonists (P2Y12 inhibitors) |
